Literature DB >> 16612175

An update on regional brain volume differences associated with mood disorders.

Stephanie Campbell1, Glenda MacQueen.   

Abstract

PURPOSE OF REVIEW: Structural brain changes are apparent in some magnetic resonance imaging studies of patients with mood disorders, but results are inconsistent. The focus of this review is to examine whether there are demographic or clinical characteristics of people with mood disorders that are associated with regional brain volume changes. A systematic search of the literature in English, from January 2004 to July 2005, was performed on MEDLINE. References cited in all reports were searched iteratively to identify missing studies. RECENT
FINDINGS: Recent studies have focused on factors that might help to reconcile the divergent reports of regional brain volume changes in major depressive disorder and bipolar disorder. Small hippocampal volumes are apparent in patients with recurrent major depressive disorder, but not generally reported early in the course of adult onset depression. Small hippocampal volumes may be apparent in patients with childhood onset illness. Small hippocampal volumes are infrequently reported in bipolar disorder, but studies to date have not accounted for illness history or treatment status. Changes in amygdala volumes are inconsistently reported in patients with major depressive disorder or bipolar disorder. There are relatively fewer reports of other brain regions, including the areas of the frontal cortex and striatum. An extensive preclinical literature suggests that various psychotropic medications may have neurotrophic and neuroprotective effects, making documentation of treatment history essential.
SUMMARY: Patients' age, sex, age at onset of disease, course of illness and treatment status may affect the detection of regional brain volume changes in people with mood disorders.

Entities:  

Mesh:

Year:  2006        PMID: 16612175     DOI: 10.1097/01.yco.0000194371.47685.f2

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  62 in total

Review 1.  Antioxidants as antidepressants: fact or fiction?

Authors:  Giovanni Scapagnini; Sergio Davinelli; Filippo Drago; Antonino De Lorenzo; Giovannangelo Oriani
Journal:  CNS Drugs       Date:  2012-06-01       Impact factor: 5.749

2.  Changes in regional brain volumes in social anxiety disorder following 12 weeks of treatment with escitalopram.

Authors:  Naseema Cassimjee; Jean-Pierre Fouche; Michael Burnett; Christine Lochner; James Warwick; Patrick Dupont; Dan J Stein; Karen J Cloete; Paul D Carey
Journal:  Metab Brain Dis       Date:  2010-11-10       Impact factor: 3.584

3.  A morphometric analysis of the septal nuclei in schizophrenia and affective disorders: reduced neuronal density in the lateral septal nucleus in bipolar disorder.

Authors:  Ralf Brisch; Hans-Gert Bernstein; Henrik Dobrowolny; Dieter Krell; Renate Stauch; Kurt Trübner; Johann Steiner; Mounir N Ghabriel; Hendrik Bielau; Rainer Wolf; Jana Winter; Siegfried Kropf; Tomasz Gos; Bernhard Bogerts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-07-07       Impact factor: 5.270

4.  Associations of current and remitted major depressive disorder with brain atrophy: the AGES-Reykjavik Study.

Authors:  M I Geerlings; S Sigurdsson; G Eiriksdottir; M E Garcia; T B Harris; T Sigurdsson; V Gudnason; L J Launer
Journal:  Psychol Med       Date:  2012-05-30       Impact factor: 7.723

Review 5.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

6.  Cognitive impairment as a mediator in the developmental pathway from infant malnutrition to adolescent depressive symptoms in Barbadian youth.

Authors:  Deborah P Waber; David Eaglesfield; Garrett M Fitzmaurice; Cyralene Bryce; Robert H Harrison; Janina R Galler
Journal:  J Dev Behav Pediatr       Date:  2011-04       Impact factor: 2.225

Review 7.  HCN Channel Targets for Novel Antidepressant Treatment.

Authors:  Stacy M Ku; Ming-Hu Han
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

8.  Hippocampal and amygdalar volumes in psychotic and nonpsychotic unipolar depression.

Authors:  Jennifer Keller; Lin Shen; Rowena G Gomez; Amy Garrett; H Brent Solvason; Allan Reiss; Alan F Schatzberg
Journal:  Am J Psychiatry       Date:  2008-05-01       Impact factor: 18.112

9.  Depressive-like behavior in mice recently recovered from motor disorders after 3-nitropropionic acid intoxication.

Authors:  Xiao-Min Li; Bing-Gen Zhu; Sha Ma; Wei Zhou; Zheng Wei; Yu-Xiang Zheng; Xu-Dong Zhao; Rong-Shen Zhu
Journal:  Neurosci Bull       Date:  2008-08       Impact factor: 5.203

10.  Combined neuroimaging, neurocognitive and psychiatric factors to predict alcohol consumption following treatment for alcohol dependence.

Authors:  Timothy C Durazzo; Stefan Gazdzinski; Ping-Hong Yeh; Dieter J Meyerhoff
Journal:  Alcohol Alcohol       Date:  2008-09-24       Impact factor: 2.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.